| Filed On | Filing |
|---|---|
| 17 Sep 2026 |
Form 4: Fordyce Marshall, Director
Received 18,500 shares by exercise or conversion ($53.6K) · Sold 18,500 shares ($685K) |
| 14 Sep 2026 |
Form 4: Young Joseph R, SVP, FINANCE, CHIEF ACCT OFFCR
Received 5,000 shares by exercise or conversion ($19.7K) |
| 04 Sep 2026 |
Form 4: Fordyce Marshall, Director
Received 18,500 shares by exercise or conversion ($53.6K) · Sold 18,500 shares ($650K) |
| 05 Aug 2026 |
Form 4: Boman Nancy Lee, Chief Regulatory Officer
Received 44,987 shares as a grant or award · Granted 63,011 Stock Option (right to buy) |
| 09 Jul 2026 |
Form 4: Fordyce Marshall, Director
Sold 46,250 shares ($1.96M) |
| 24 Jun 2026 |
Form 4: Fordyce Marshall, Director
Sold 18,500 shares ($702K) |
| 26 May 2026 |
Form 4: Morrison Scott W, Director
Granted 17,084 Stock Option (right to buy) |
| 26 May 2026 |
Form 4: Cheng Andrew, Director
Granted 17,084 Stock Option (right to buy) |
| 26 May 2026 |
Form 4: Seidenberg Beth C, Director
Granted 17,084 Stock Option (right to buy) |
| 26 May 2026 |
Form 4: Oliger Christy J., Director
Granted 17,084 Stock Option (right to buy) |
| 26 May 2026 |
Form 4: Meyers James R, Director
Granted 17,084 Stock Option (right to buy) |
| 26 May 2026 |
Form 4: Hall Kimball, Director
Granted 17,084 Stock Option (right to buy) |
| 26 May 2026 |
Form 4: Morrissey Michael, Director
Granted 17,084 Stock Option (right to buy) |
| 26 May 2026 |
Form 4: Enright Patrick G, Director
Granted 17,084 Stock Option (right to buy) |
| 13 May 2026 |
Form 4: Fordyce Marshall, Director
Sold 18,500 shares ($680K) |
| 15 Apr 2026 |
Form 4: Fordyce Marshall, Director
Sold 22,951 shares ($1.01M) |
| 25 Mar 2026 |
Form 4: Wright-Mitchell Jane, Chief Legal Officer
Received 42,403 shares as a grant or award · Granted 56,850 Stock Option (right to buy) |
| 16 Mar 2026 |
Form 4: Young Joseph R, SVP, FINANCE, CHIEF ACCT OFFCR
Received 10,000 shares by exercise or conversion ($39.4K) |
| 09 Mar 2026 |
Form 4: Hite Christopher, Director
Granted 24,937 Stock Option (right to buy) |
| 25 Feb 2026 |
Form 4: Brenner Robert, Chief Medical Officer
Sold 2,151 shares ($90.3K) |
Loading...